A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.

UK medicines watchdog the Medicines and Healthcare Products Regulatory Agency (MHRA) stuck an alert on one batch of the ...

The MHRA has revealed it's received more than 560 reports of acute pancreatitis in patients taking GLP-1 injections since ...

Depression and anxiety are the most common psychiatric disorders in the world. Around 300 million people suffer from ...

Take Back Program offers a safe way to dispose of unwanted prescription and over-the-counter medicines free of charge.

Arrest reports shed light on how the alleged drug ring operated after a variety of medications prescribed to family members ...

Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for ...

Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year ...

Eli Lilly’s tirzepatide is expected to be worth $62 billion annually by 2030, according to Evaluate. That valuation would be ...

So-called ‘skinny jabs’ are being prescribed to people who don’t need them, with terrifying side effects. How did our ...

FDA’s public guidance continues to warn that, “under most circumstances,” importing drugs for personal use is unlawful, ...